William Blair & Company’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.29K | Sell |
22,089
-950
| -4% | -$313 | ﹤0.01% | 1752 |
|
|
2025
Q1 | $7.19K | Hold |
23,039
| – | – | ﹤0.01% | 1734 |
|
|
2024
Q4 | $21.5K | Sell |
23,039
-9,000
| -28% | -$8.4K | ﹤0.01% | 1683 |
|
|
2024
Q3 | $37.8K | Buy |
32,039
+1,000
| +3% | +$1.18K | ﹤0.01% | 1662 |
|
|
2024
Q2 | $23.9K | Buy |
31,039
+7,100
| +30% | +$5.46K | ﹤0.01% | 1677 |
|
|
2024
Q1 | $73K | Buy |
23,939
+2,263
| +10% | +$6.9K | ﹤0.01% | 1552 |
|
|
2023
Q4 | $69.8K | Sell |
21,676
-401
| -2% | -$1.29K | ﹤0.01% | 1550 |
|
|
2023
Q3 | $84.8K | Sell |
22,077
-1,250
| -5% | -$4.8K | ﹤0.01% | 1525 |
|
|
2023
Q2 | $76.5K | Sell |
23,327
-1,001
| -4% | -$3.28K | ﹤0.01% | 1545 |
|
|
2023
Q1 | $62.8K | Hold |
24,328
| – | – | ﹤0.01% | 1552 |
|
|
2022
Q4 | $45.3K | Sell |
24,328
-6,900
| -22% | -$12.8K | ﹤0.01% | 1588 |
|
|
2022
Q3 | $57K | Hold |
31,228
| – | – | ﹤0.01% | 1582 |
|
|
2022
Q2 | $67K | Sell |
31,228
-27,137
| -46% | -$58.2K | ﹤0.01% | 1590 |
|
|
2022
Q1 | $183K | Sell |
58,365
-32,487
| -36% | -$102K | ﹤0.01% | 1540 |
|
|
2021
Q4 | $292K | Sell |
90,852
-6,146
| -6% | -$19.8K | ﹤0.01% | 1435 |
|
|
2021
Q3 | $326K | Sell |
96,998
-19,762
| -17% | -$66.4K | ﹤0.01% | 1315 |
|
|
2021
Q2 | $457K | Sell |
116,760
-39,722
| -25% | -$155K | ﹤0.01% | 1177 |
|
|
2021
Q1 | $629K | Buy |
156,482
+18,822
| +14% | +$75.7K | ﹤0.01% | 1050 |
|
|
2020
Q4 | $318K | Sell |
137,660
-27,076
| -16% | -$62.5K | ﹤0.01% | 1240 |
|
|
2020
Q3 | $946K | Buy |
164,736
+87,180
| +112% | +$501K | ﹤0.01% | 772 |
|
|
2020
Q2 | $572K | Buy |
77,556
+12,556
| +19% | +$92.6K | ﹤0.01% | 896 |
|
|
2020
Q1 | $194K | Sell |
65,000
-125,253
| -66% | -$374K | ﹤0.01% | 1174 |
|
|
2019
Q4 | $790K | Buy |
+190,253
| New | +$790K | ﹤0.01% | 846 |
|